Sofregen Medical Inc. — Form D/A
Sofregen Medical Inc. of MEDFORD, MA, a company, filed a Form D amendment with the SEC on 2017-09-27. The offering totals $9.7M, of which $9.7M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2017-09-27
- Form: D/A
- Accession: 0001140361-17-036641
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $9.7M
- Amount sold: $9.7M
- Investors: 7
- Date of first sale: 2016-09-13
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-271393
Issuer
- Name: Sofregen Medical Inc.
- CIK: 0001685282
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 200 BOSTON AVENUE, SUITE 1100, MEDFORD, MA, 02155
- Phone: 617-651-8873
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| AMIR NASHAT | Director | San Diego, CA |
| Doug Sheldon | Director | Cambridge, MA |
| Anh Hoang | Executive Officer | Cambridge, MA |
| Milan Kofol | Executive Officer | Cambridge, MA |
| Anh Hoang-Lindsay | Director | Watertown, MA |
| Howard Weisman | Director | Tarrytown, NY |
| Howard Weisman | Executive Officer | Tarrytown, NY |
| S. Douglas Sheldon | Director | Medford, MA |
Other filings by this issuer (2)
More